Literature DB >> 22411096

Activation and regulation of interferon-β in immune responses.

Wei-Xiang Sin1, Peng Li, Joe Poh-Sheng Yeong, Keh-Chuang Chin.   

Abstract

Interferons (IFNs) were discovered more than half a century ago, and extensive research has since identified multifarious roles for type I IFN in human immune responses. Here, we review the functions of IFN-β in innate and adaptive immunity. We also discuss the activation and influence of IFN-β on myeloid cell types, including monocytes and dendritic cells, as well as address the effects of IFN-β on T cells and B cells. Findings from our own laboratory, which explores the molecular mechanisms of IFN-β activation by LPS and viruses, as well as from other groups investigating the regulation of IFN-β by viral proteins and endogenous factors are described. The effects of post-translational modifications of the interferon regulatory factor (IRF)-3 on IFN-β induction are also highlighted. Many unanswered questions remain concerning the regulation of the type I IFN response in inflammation, especially the role of transcription factors in the modulation of inflammatory gene expression, and these questions will form the basis for exciting avenues of future research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411096     DOI: 10.1007/s12026-012-8293-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  180 in total

1.  T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.

Authors:  Robert C Axtell; Brigit A de Jong; Katia Boniface; Laura F van der Voort; Roopa Bhat; Patrizia De Sarno; Rodrigo Naves; May Han; Franklin Zhong; Jim G Castellanos; Robert Mair; Athena Christakos; Ilan Kolkowitz; Liat Katz; Joep Killestein; Chris H Polman; René de Waal Malefyt; Lawrence Steinman; Chander Raman
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

Review 2.  Should we inhibit type I interferons in sepsis?

Authors:  Tina Mahieu; Claude Libert
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

3.  Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells.

Authors:  Giuseppe Mancuso; Maria Gambuzza; Angelina Midiri; Carmelo Biondo; Salvatore Papasergi; Shizuo Akira; Giuseppe Teti; Concetta Beninati
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

Review 4.  Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

Authors:  Lynn Verstrepen; Kelly Verhelst; Geert van Loo; Isabelle Carpentier; Steven C Ley; Rudi Beyaert
Journal:  Biochem Pharmacol       Date:  2010-07-03       Impact factor: 5.858

5.  Inhibition of B cell receptor-mediated apoptosis by IFN.

Authors:  L Su; M David
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

6.  Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development.

Authors:  C A Wenner; M L Güler; S E Macatonia; A O'Garra; K M Murphy
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

7.  Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase.

Authors:  K Ruuth; L Carlsson; B Hallberg; E Lundgren
Journal:  Biochem Biophys Res Commun       Date:  2001-06-15       Impact factor: 3.575

8.  Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2.

Authors:  Stephen E Girardin; Leonardo H Travassos; Mireille Hervé; Didier Blanot; Ivo G Boneca; Dana J Philpott; Philippe J Sansonetti; Dominique Mengin-Lecreulx
Journal:  J Biol Chem       Date:  2003-07-18       Impact factor: 5.157

9.  Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.

Authors:  P Lindahl; I Gresser; P Leary; M Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

10.  Interferon-alpha triggers B cell effector 1 (Be1) commitment.

Authors:  Marie-Ghislaine de Goër de Herve; Deniz Durali; Bamory Dembele; Massimo Giuliani; Tu-Anh Tran; Bruno Azzarone; Pierre Eid; Marc Tardieu; Jean-François Delfraissy; Yassine Taoufik
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more
  27 in total

Review 1.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

2.  Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.

Authors:  Paurvi Shinde; Wenhai Liu; Antoine Ménoret; Andrew D Luster; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2017-04-21       Impact factor: 4.962

Review 3.  [Immunosuppressives to prevent rejection reactions after allogeneic corneal transplantation].

Authors:  T Lapp; P Maier; F Birnbaum; G Schlunck; T Reinhard
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

Review 4.  Absent in Melanoma 2 proteins in SLE.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Clin Immunol       Date:  2017-01-03       Impact factor: 3.969

Review 5.  Inositol pyrophosphates: why so many phosphates?

Authors:  Stephen B Shears
Journal:  Adv Biol Regul       Date:  2014-10-05

6.  The Akt1 isoform is required for optimal IFN-β transcription through direct phosphorylation of β-catenin.

Authors:  Benjamin N Gantner; Huali Jin; Feng Qian; Nissim Hay; Bin He; Richard D Ye
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

7.  Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Díaz-San Segundo; Danielle Hickman; Charles R Long; James Zhu; Luis L Rodríguez; Teresa de los Santos
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

8.  The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection.

Authors:  Chelsea Pinkham; Soyeon An; Lindsay Lundberg; Neha Bansal; Ashwini Benedict; Aarthi Narayanan; Kylene Kehn-Hall
Journal:  Virology       Date:  2016-06-16       Impact factor: 3.616

9.  Endobiont viruses sensed by the human host - beyond conventional antiparasitic therapy.

Authors:  Raina N Fichorova; Yujin Lee; Hidemi S Yamamoto; Yuko Takagi; Gary R Hayes; Russell P Goodman; Xenia Chepa-Lotrea; Olivia R Buck; Ryan Murray; Tomasz Kula; David H Beach; Bibhuti N Singh; Max L Nibert
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells.

Authors:  Fabian Wolpert; Caroline Happold; Guido Reifenberger; Ana-Maria Florea; René Deenen; Patrick Roth; Marian Christoph Neidert; Katrin Lamszus; Manfred Westphal; Michael Weller; Günter Eisele
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.